[1] World Health Organization. Global Report on Diabetes. Geneva: World Health Organization, 2016.
[2] Khetan AK, Rajagopalan S. Prediabetes[J]. Can J Cardiol. 2018, 34(5):615-623.
[3] Cho HJ, Hwang S, Park JI, et al. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus[J]. Gut Liver, 2019, 13(4):440-449.
[4] Gerhard GS, Benotti P, Wood GC, et al. Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity[J]. J Obes, 2014, 2014:368210.
[5] Kaneko K, Yatsuya H, Li Y, et al. Association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow up[J]. J Diabetes Investig, 2019, 10(3):837-845.
[6] Kwon SS, Lee SG. A High Alanine Aminotransferase/Aspartate Aminotransferase Ratio Determines Insulin Resistance and Metabolically Healthy/Unhealthy Obesity in a General Adult Population in Korea: The Korean National Health and Nutritional Examination Survey 2007- 2010[J]. Exp Clin Endocrinol Diabetes, 2019, 127(10):677-684.
[7] Nunez DJ, Alexander M, Yerges-Armstrong L, et al. Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316(3):G372-G386.
[8] Bussler S, Vogel M, Pietzner D, et al. New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage[J]. Hepatology, 2018, 68(4):1319-1330.
[9] Wang H, Li L, Zhang S. Non-linear relationship between gamma-glutamyl transferase and type 2 diabetes mellitus risk: secondary analysis of a prospective cohort study[J]. J Int Med Res, 2020, 48(7):300060520937911.
[10] Zhao W, Tong J, Liu J, et al. The Dose-Response Relationship between Gamma-Glutamyl Transferase and Risk of Diabetes Mellitus Using Publicly Available Data: A Longitudinal Study in Japan[J]. Int J Endocrinol, 2020, 2020:5356498.
[11] Hozawa A, Okamura T, Tanaka T, et al. Relation of Gamma-glutamyltransferase and alcohol drinking with incident diabetes: the HIPOP-OHP study[J]. J Atheroscler Thromb, 2010, 17(2):195-202.
[12] Yu JH, Kim JS, Lee MR, et al. Risks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workers[J]. Ann Occup Environ Med, 2016, 28:18.
[13] Zhao W, Zhang L, Zhang G, et al. The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies[J]. Acta Diabetol, 2020, 57(6):635-644.
[14] Noordam R, Smit RA, Postmus I, et al. Assessment of causality between serum gamma-glutamyltransferase and type 2 diabetes mellitus using publicly available data: a Mendelian randomization study[J]. Int J Epidemiol, 2016, 45(6):1953-1960.
[15] Liu J, Au Yeung SL, Lin SL, et al. Liver enzymes and risk of ischemic heart disease and type 2 diabetes mellitus: a Mendelian randomization study[J]. Sci Rep, 2016, 6:38813.
[16] Conen D, Vollenweider P, Rousson V et al. Use of a Mendelian randomization approach to assess the causal relation of gammaGlutamyltransferase with blood pressure and serum insulin levels[J]. Am J Epidemioldemi, 2010, 172(2):1431-1441.
[17] Lee YS, Cho Y, Burgess S et al. Serum gamma-glutamyl transferase and risk of type 2 diabetes in the general Korean population: a Mendelian randomization study. Hum Mol Genet, 2016, 25(17):3877-3886.
[18] De Silva NMG, Borges MC, Hingorani AD, et al. Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study[J]. Diabetes, 2019, 68(8):1681-1691.
[19] Nano J, Muka T, Ligthart S, et al. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study[J]. Int J Epidemiol, 2017, 46(5):1400-1409.
[20] Li Y, Schoufour J, Wang DD, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study[J]. BMJ, 2020, 368:l6669.
[21] Shan Z, Li Y, Zong G, et al. Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses[J]. BMJ, 2018, 363:k4641.